Literature DB >> 30874448

Relationship of Postpartum Levels of Cystatin and High-Sensitivity C-Reactive Protein and Duration of Lactation in Mothers with Previous Gestational Hypertension or Preeclampsia.

Malamo E Countouris1, Jill R Demirci2, Arun Jeyabalan3, Janet M Catov4, Eleanor B Schwarz5.   

Abstract

Background: Women with hypertensive disorders of pregnancy are at increased risk of cardiovascular disease in later life. We sought to determine the association between lactation and markers of maternal cardiovascular health among postpartum women with and without hypertensive disorders of pregnancy via measures of inflammation (high-sensitivity C-reactive protein [hsCRP]) and renal function (cystatin C). Materials and
Methods: This prospective cohort study enrolled primarily overweight and obese women during early pregnancy. At a postpartum study visit occurring 6-24 months after delivery, we collected data on lactation duration and measured hsCRP and cystatin C. We assessed associations between lactation duration and levels of hsCRP and cystatin C among normotensive women and women with preeclampsia or gestational hypertension using analysis of variance and chi-squared tests. Linear regression models adjusted for age, race, education, prepregnancy body mass index, current smoking, and time since delivery.
Results: Of 425 women, 37 (9%) had preeclampsia and 48 (11%) had gestational hypertension during enrollment pregnancy. The postpartum visit occurred at a mean of 8.6 ± 4.4 months after delivery. Women with a history of preeclampsia had significantly higher levels of cystatin C (mean 0.86 versus 0.78 mg/L; p = 0.03) compared with normotensive women, but nonsignificant elevation in hsCRP (mean 8.39 versus 6.04 mg/L; p = 0.08). Women with gestational hypertension had no differences in mean hsCRP or cystatin C compared with normotensive women. Among the 237 women with any lactation, 78 (18%) lactated for at least 6 months. Lactation duration both in the overall sample and among women with gestational hypertension or preeclampsia was not associated with levels of hsCRP or cystatin C. Conclusions: Preeclampsia history was associated with elevated postpartum levels of cystatin C; however, duration of lactation was not associated with postpartum hsCRP or cystatin C, regardless of history of gestational hypertension or preeclampsia. Further research is needed on mechanisms through which lactation may affect maternal risk of cardiovascular disease.

Entities:  

Keywords:  cystatin C; gestational hypertension; high-sensitivity C-reactive protein; lactation; preeclampsia

Mesh:

Substances:

Year:  2019        PMID: 30874448      PMCID: PMC6648190          DOI: 10.1089/bfm.2018.0153

Source DB:  PubMed          Journal:  Breastfeed Med        ISSN: 1556-8253            Impact factor:   1.817


  47 in total

1.  Elevated C-reactive protein levels in overweight and obese adults.

Authors:  M Visser; L M Bouter; G M McQuillan; M H Wener; T B Harris
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

Review 2.  The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review.

Authors:  Christos Kasapis; Paul D Thompson
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

3.  Is the association between socioeconomic position and coronary heart disease stronger in women than in men?

Authors:  Rebecca C Thurston; Laura D Kubzansky; Ichiro Kawachi; Lisa F Berkman
Journal:  Am J Epidemiol       Date:  2005-07-01       Impact factor: 4.897

4.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

5.  Breastfeeding status and maternal cardiovascular variables across the postpartum.

Authors:  Maureen W Groer; Cecilia M Jevitt; Frances Sahebzamani; Jason W Beckstead; David L Keefe
Journal:  J Womens Health (Larchmt)       Date:  2013-05       Impact factor: 2.681

6.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Authors:  Paul M Ridker; Nader Rifai; Lynda Rose; Julie E Buring; Nancy R Cook
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

7.  Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.

Authors:  Rudolf A de Boer; Matthew Nayor; Christopher R deFilippi; Danielle Enserro; Vijeta Bhambhani; Jorge R Kizer; Michael J Blaha; Frank P Brouwers; Mary Cushman; Joao A C Lima; Hossein Bahrami; Pim van der Harst; Thomas J Wang; Ron T Gansevoort; Caroline S Fox; Hanna K Gaggin; Willem J Kop; Kiang Liu; Ramachandran S Vasan; Bruce M Psaty; Douglas S Lee; Hans L Hillege; Traci M Bartz; Emelia J Benjamin; Cheeling Chan; Matthew Allison; Julius M Gardin; James L Januzzi; Sanjiv J Shah; Daniel Levy; David M Herrington; Martin G Larson; Wiek H van Gilst; John S Gottdiener; Alain G Bertoni; Jennifer E Ho
Journal:  JAMA Cardiol       Date:  2018-03-01       Impact factor: 14.676

8.  C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.

Authors:  Mary Cushman; Alice M Arnold; Bruce M Psaty; Teri A Manolio; Lewis H Kuller; Gregory L Burke; Joseph F Polak; Russell P Tracy
Journal:  Circulation       Date:  2005-06-27       Impact factor: 29.690

9.  Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis.

Authors:  Cande V Ananth; Katherine M Keyes; Ronald J Wapner
Journal:  BMJ       Date:  2013-11-07

Review 10.  Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.

Authors:  Thijs C van Holten; Leonie F Waanders; Philip G de Groot; Joost Vissers; Imo E Hoefer; Gerard Pasterkamp; Menno W J Prins; Mark Roest
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.